Looks like you’re on the UK site. Choose another location to see content specific to your location

HomeBlog Pharmaceutical Navigating the Rise of Specialty Medicines: What It Means for Commercial Structures
Medicines

Navigating the Rise of Specialty Medicines: What It Means for Commercial Structures

1st August 2025
Sophie
Posted by
Sophie Andrews

Despite facing constant change, the shift towards specialty medicines within the pharmaceutical industry seems particularly significant.

These aren’t one size fits all products of the past. They are complex biologics or precision therapies targeted towards smaller groups that have more intensive treatment pathways and a greater need for clinical support. And as these therapies become more central to pharma pipelines, we’re seeing a very real impact on how companies are structuring their commercial teams.

As someone who is responsible for commercial pharmaceutical recruitment landscape everyday, I’ve noticed how many clients are rethinking what “good” looks like in a customer-facing role. It’s no longer just about product knowledge and sales numbers, it’s about being able to support clinicians through challenging treatment decisions, reimbursement questions, and a far more involved patient journey.

A More Demanding Market:
What’s becoming clear is that speciality medicines demand a more informed, more consultative approach. Customers, whether they’re specialists in rare disease or pharmacists navigating market access, want to speak with people who understand the therapy area deeply. It’s a shift away from volume-driven models and towards value-based engagement.

In response, many companies are redesigning roles entirely, moving from traditional sales rep models to hybrid roles that combine elements of medical, commercial and access. There is also a growing demand for MSLs, KAMs and professionals who are able to operate cross-functionally from day one. For further detail, visit our Pharmaceutical Sales Recruitment page.

It is not about hiring more people, its about hiring differently.

The Role of Recruitment to Get it Right:
Our role at Zenopa is to help clients keep pace with these changes. That doesn’t just mean sending CVs, it means having the conversations early on about how teams need to evolve, what the talent market looks like, and how to find people who can thrive in these more specialist environments.

We work with businesses launching into rare disease, oncology, advanced therapies and more, helping them identify people who aren’t just capable, but credible. People who can build real trust with healthcare professionals and navigate the complexity that comes with high-science products.

Looking Ahead:
Speciality medicines aren’t a side story anymore, they’re becoming the centre of many pharma strategies. And if the product is evolving, the structure around it needs to evolve too.

If your team is preparing for a product launch, restructuring for growth, or simply unsure whether your current setup is fit for the future, we’re here to support you. Our experience across the UK pharmaceutical market means we can advise, adapt and deliver, all with the long-term success of your team in mind.

To explore how Zenopa can support your Pharmaceutical Recruitment strategy, get in touch.

imaging 4

From Diagnostic to Preventative: The Commercial Impact of Early Imaging Trends

Next article

Stay informed

Receive the latest industry news, Tips and straight to your inbox.